Chlorhexidine Gluconate (CHG) Wipes Market Report 2026

Chlorhexidine Gluconate (CHG) Wipes Market Overview

• Chlorhexidine Gluconate (CHG) Wipes market size has reached to $52.53 billion in 2025 • Expected to grow to $70.45 billion in 2030 at a compound annual growth rate (CAGR) of 6.5% • Growth Driver: Surge In Surgical Procedures Fuels Growth In Chlorhexidine Gluconate (CHG) Wipes Market • Market Trend: Antiseptic Solution To Address Growing Demand For Comprehensive Microbial Protection • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Chlorhexidine Gluconate (CHG) Wipes Market?

Chlorhexidine gluconate (CHG) wipes are disinfectant wipes infused with chlorhexidine gluconate, widely used in healthcare environments to cleanse the skin and reduce the risk of infections. They are especially effective for pre-surgical skin preparation, offering prolonged antimicrobial action by eliminating or limiting bacteria on the skin. The main types of chlorhexidine gluconate (CHG) wipes are chlorhexidine gluconate (CHG) bath wipes and chlorhexidine gluconate (CHG) alcohol-based wipes. Chlorhexidine gluconate (CHG) bath wipes refer to disposable antiseptic wipes that enable hospital patients to bathe without having to rinse and are used to wash skin and prevent skin infections. The different applications include surgical site infections, central line-associated bloodstream infections, catheter-associated urinary tract infections, and others. These are distributed by pharmacies, supermarkets, specialty stores, and direct sale channels for hospitals, clinics, ambulatory surgical centers, and others.

What Is The Chlorhexidine Gluconate (CHG) Wipes Market Growth Forecast?

The chlorhexidine gluconate (chg) wipes market size is expected to see strong growth in the next few years. It will grow to $70.45 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to development of advanced chg-infused wipes, expansion of infection prevention programs, increasing adoption in ambulatory surgical centers, rising awareness of multi-drug resistant organisms, integration with hospital digital hygiene monitoring systems. Major trends in the forecast period include rising adoption of pre-surgical skin preparation wipes, growing awareness about hospital-acquired infections (hais), expansion of central line and catheter-associated infection prevention, increased use of alcohol-based antiseptic wipes, enhanced focus on hygiene and sterilization protocols.

Global Chlorhexidine Gluconate (CHG) Wipes Market Segmentation

1) By Type: Chlorhexidine Gluconate (CHG) Bath Wipes, Chlorhexidine Gluconate (CHG) Alcohol-Based Wipes 2) By Application: Surgical Site Infections, Central Line-Associated Bloodstream Infections, Catheter-Associated Urinary Tract Infections, Other Applications 3) By Distribution Channel: Pharmacies, Supermarkets, Specialty Stores, Direct Sales 4) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Chlorhexidine Gluconate (CHG) Bath Wipes: Pre-Packaged Bath Wipes, Disposable Bath Cloths 2) By Chlorhexidine Gluconate (CHG) Alcohol-Based Wipes: Antiseptic Wipes, Surface Disinfection Wipes

What Is The Driver Of The Chlorhexidine Gluconate (CHG) Wipes Market?

The increase in surgical procedures is expected to propel the growth of the chlorhexidine gluconate (CHG) wipes market going forward. A surgical procedure involves making an incision and using tools to stop or repair disease in a living body. Chlorhexidine gluconate (CHG) wipes are used in vast and varied surgical procedures to clean potentially hazardous microbes on the skin and prevent the growth of more microbes. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization, aesthetic procedures reached nearly 35 million in 2023, with the total number of surgical and non-surgical procedures rising by 3.4% to 34.9 million. Therefore, the increase in surgical procedures drives the growth of the chlorhexidine gluconate (CHG) wipes industry.

Key Players In The Global Chlorhexidine Gluconate (CHG) Wipes Market

Major companies operating in the chlorhexidine gluconate (chg) wipes market are Cardinal Health Inc., 3M Co, Johnson & Johnson MedTech, McKesson Medical-Surgical Inc., Medline Industries Inc., Becton Dickinson and Company, Stryker Corporation, Ecolab Inc., Smith & Nephew Plc., Ethicon Inc., Coloplast AS, Purdue Products L.P, Owens & Minor Inc., Pal International, Molnlycke Health Care AB, Halyard Health Inc., Nice-Pak Products Inc., Sage Products LLC, GAMA Healthcare Ltd., Dynarex-Corporation, AvaCare Medical LLC, PDI Ltd., Lernapharm Inc., Carenow Medical Pvt. Ltd., Clinicept Healthcare Ltd.

Global Chlorhexidine Gluconate (CHG) Wipes Market Trends and Insights

Major companies operating in the chlorhexidine gluconate (CHG) wipes market are focused on developing innovative products such as antiseptic solution to enhance their product offerings and meet the increasing demand for effective and versatile antiseptic solutions. An antiseptic solution is a liquid preparation that kills or inhibits the growth of microorganisms (like bacteria, viruses, and fungi) on living tissue. For instance, in June 2023, HR Pharmaceuticals Inc., a US-based company that specializes in healthcare consumables, unveiled CliniClean Chlorhexidine Gluconate (CHG) 4%, an antiseptic solution designed for comprehensive skin protection against diverse microorganisms, lowering the risk of healthcare-associated and surgical site infections. This versatile antiseptic/antimicrobial formula is suitable for patient pre-operative preparation, surgical hand scrubs, healthcare personnel handwashing, and general skin and wound cleansing. Through repeated use, CliniClean has clinically demonstrated a substantial reduction in skin bacteria, with continued germ-fighting efficacy for extended periods after application.

What Are Latest Mergers And Acquisitions In The Chlorhexidine Gluconate (CHG) Wipes Market?

In July 2023, Solenis, a US-based provider of specialty chemicals for water-intensive industries, acquired Diversey for $4.6 billion. With this acquisition, Solenis aims to expand its global scale and diversify its offerings by integrating complementary cleaning, hygiene, and water management solutions to better serve a broader customer base. Diversey is a US-based provider of hygiene, infection prevention, and cleaning products and technologies including CHG wipes.

Regional Outlook

North America was the largest region in the chlorhexidine gluconate (CHG) wipes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Chlorhexidine Gluconate (CHG) Wipes Market?

The chlorhexidine gluconate (CHG) wipes market consists of sales of skin antiseptic wipes, pre-surgery wash sponges, and surgical skin disinfectants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.